BlackRock »

Indivior Pharmaceuticals shares owned by BlackRock

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by BlackRock

Quarter filed Position value Share count Share price at filing
2026-03-31 $565M 19M 30.48

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)

View all positions for BlackRock

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Madison Avenue Partners
Vanguard Capital Management
Two Seas Capital
Millennium Management
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Goldman Sachs Group
UBS Group
Driehaus Capital Management
Newtyn Management

View all funds holding Indivior Pharmaceuticals